Access the updated page using the API Locator.   Our Custom Search for Pharma News…

FDA Approval Activities for this Drug… Betaxon (levobetaxolol hydrochloride ophthalmic suspension),0.5%, Alcon Universal,Limited NDA 21-114 2/29/00 Betaxon Indication: for lowering intraocular pressure in patients with chronic open-angle glaucoma or ocular hypertension. Dosage form/route of administration is new. | BETAXON (levobetaxolol hydrochloride ophthalmic suspension), Alcon Research, Efficacy Supp. w/Clinical Data | Betaxon (levobetaxolol hydrochloride) Ophthalmic Suspension, Alcon Research, Ltd., Labeling Revision View updates.                                                                       A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | For Industry | DMF Index | Pharma Job Search | Pharma Company News | VOIP © 2012 Betterchem.com